Gapping down
In reaction to disappointing earnings/guidance: ZUMZ -10.4%, (Zumiez beats by $0.03, reports revs in-line; guides Q2 below consensus; reports May same store sales -7.6% vs -6.4% Retail Metrics consensus)
Other news: WRES -25.9% (continued weakness following reports that the company has filed for bankruptcy protection), IMMU -17.5% (removed from ASCO this weekend because it has no new update to its breast cancer data), ONTY -7.4% (enters into sales agreement to sell up to $50 mln of its common shares from time-to-time), BLDP -2.9% ( files for $100 mln mixed securities shelf offering ), CC -2.7% (Chemours responds to the report by Citron Research issued today; reaffirms 2016 outlook), ISR -2.2% (provides update on its pending securities lawsuit; Judge Suko entered an order denying IsoRay's motion to dismiss)
Analyst comments: PCAR -0.6% (downgraded to Neutral from Buy at Goldman)